GLMD - Galmed Pharmaceuticals Ltd Stock Trading

Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results - Conference Call and Webcast Today at 8:30 a.m. ET / 5:30 a.m. PT - PR Newswire TEL AVIV, Israel , March 18, 2021 /PRNewswire/ -- Galmed Pharmaceut...

Galmed Pharmaceuticals Announces Dosing of First Subject in First in Human Phase 1 Trial of Amilo-5MER Amilo-5MER is believed to have significant effect in the treatment of chronic inflammation PR Newswire TEL AVIV, Israel , March 16, 2021 /PRNewswire/ -- Gal...

Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2020 Financial Results and Provide Business Update on Thursday March 18 PR Newswire TEL AVIV, Israel , March 11, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company...